PhaseBio Pharmaceuticals, Inc. PHAS

Full chart Compare
Set alert

Price alert · PHAS

All alert types
0.07 0.00 (+0.00%)

At closeNov 2, 2022, 4:00 PM EDT

0.0665 Day range 0.092

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $10.83KGross Profit → Expenses: $10.83KExpenses → Selling, General & Admin: $16.09KExpenses → Research & Development: $102.11KExpenses → Other Expenses: $22.11KExpenses → Income Tax: $1.60KNet Loss → Expenses: $131.07KGross Profit$10.83KNet Loss$131.07KExpenses$141.90KSelling, General & Admin$16.09KResearch & Development$102.11KOther Expenses$22.11KIncome Tax$1.60KRevenue$10.83K

No annual statement lines

PHAS has no annual lines for this statement.